CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 96 filers reported holding CYTOSORBENTS CORP in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $27,000 | -52.6% | 12,531 | -29.8% | 0.00% | – |
| Q1 2022 | $57,000 | -21.9% | 17,858 | +84.4% | 0.00% | -100.0% |
| Q2 2021 | $73,000 | -33.6% | 9,682 | -23.8% | 0.00% | 0.0% |
| Q1 2021 | $110,000 | -63.3% | 12,701 | -66.2% | 0.00% | -75.0% |
| Q4 2020 | $300,000 | -62.4% | 37,610 | -62.4% | 0.00% | -66.7% |
| Q3 2020 | $798,000 | +26.1% | 100,095 | +56.6% | 0.01% | +9.1% |
| Q2 2020 | $633,000 | – | 63,938 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skylands Capital, LLC | 815,869 | $3,141,000 | 0.46% |
| Sargent Investment Group, LLC | 499,010 | $1,921,000 | 0.36% |
| Anson Funds Management LP | 74,440 | $287,000 | 0.33% |
| One68 Global Capital, LLC | 39,241 | $151,000 | 0.33% |
| Granahan Investment Management | 678,618 | $2,613,000 | 0.12% |
| Winning Points Advisors, LLC | 30,000 | $115,000 | 0.07% |
| Avenir Corp | 150,600 | $580,000 | 0.06% |
| HighMark Wealth Management LLC | 10,000 | $38,000 | 0.04% |
| Wealthcare Advisory Partners LLC | 62,279 | $240,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 64,970 | $250,000 | 0.03% |